CARLOS SANTIVANEZ: Open Payments
NPI 1992767586 · HANFORD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,663 in 118 payments from 25 companies in 2025. Trend: 2023 $2,755 · 2024 $2,140 · 2025 $2,663
Food & beverage: $2,663
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $494 |
| AstraZeneca Pharmaceuticals LP | 18 | $490 |
| PFIZER INC. | 14 | $196 |
| Lilly USA, LLC | 5 | $171 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $158 |
| Lundbeck LLC | 10 | $136 |
| Novo Nordisk Inc | 5 | $114 |
| Dexcom, Inc. | 4 | $109 |
| Braeburn Inc. | 5 | $109 |
| Merck Sharp & Dohme LLC | 4 | $99 |
Products named: UBRELVY, JARDIANCE, BREZTRI, REXULTI, NURTEC ODT, FARXIGA, AIRSUPRA, Dexcom G6 Transmitter.
Industry payments across CA — which companies pay providers there.
